Mucormycosis in 2023: an update on pathogenesis and management

By sjmartinez • October 9, 2023

Alqarihi A, Kontoyiannis DP, Ibrahim AS. Mucormycosis in 2023: an update on pathogenesis and management. Front Cell Infect Microbiol. 2023 Sep 21;13:1254919. doi: 10.3389/fcimb.2023.1254919. PMID: 37808914; PMCID: PMC10552646.

Tags: COVID-19-associated mucormycosis, DKA, Harbor UCLA, immunosuppression, Infectious Diseases, invasive fungal infections, Mucorales, mucormycosis, pathogenicity, Publications, Rhizopus

Coronary Inflammation Is Associated With Plaque Progression in Men With HIV

Nasrallah N, Atallah M, Lattouf C, Harb T, Gerstenblith G, Haberlen S, Kelesidis T, Magnani JW, Stosor V, Chan K, Shirodaria C, Brown TT, Hays[...]

Metastatic Cutaneous Apocrine Carcinoma: Diagnostic and Therapeutic Challenges in a Rare Malignancy

Chan BL, Iguh C, Hwang A, Huang C. Metastatic Cutaneous Apocrine Carcinoma: Diagnostic and Therapeutic Challenges in a Rare Malignancy. Cureus. 2026 Jul 21;18(7):e113113. doi:[...]

The future of home oxygen therapy

Holland AE, Krishnan JA, Lacasse Y, Gomes H, Björklund F, Casaburi R, de Andrade J, Eakin MN, Hui D, Jacobs SS, Kawachi S, Khor YH,[...]